844 related articles for article (PubMed ID: 31375594)
21. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
22. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
23. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
Elbasani E; Gramolelli S; Günther T; Gabaev I; Grundhoff A; Ojala PM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
[TBL] [Abstract][Full Text] [Related]
25. ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Li X; Du S; Avey D; Li Y; Zhu F; Kuang E
J Virol; 2015 Jul; 89(13):6895-906. PubMed ID: 25903346
[TBL] [Abstract][Full Text] [Related]
26. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
Uppal T; Meyer D; Agarwal A; Verma SC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
[TBL] [Abstract][Full Text] [Related]
27. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
28. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM; Wind E; Papp B; Toth Z
J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
[TBL] [Abstract][Full Text] [Related]
30. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
[TBL] [Abstract][Full Text] [Related]
31. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
32. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of ATF4-LAMP3 Axis by ORF45 Facilitates Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Sun Q; Wang F; Chen Q; Sarid R; Li X; Kuang E
J Virol; 2022 Dec; 96(23):e0145622. PubMed ID: 36377873
[TBL] [Abstract][Full Text] [Related]
34. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
[TBL] [Abstract][Full Text] [Related]
35. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
36. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
37. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
[TBL] [Abstract][Full Text] [Related]
38. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.
Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F
J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309
[TBL] [Abstract][Full Text] [Related]
40. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
